Impact of access to treatment on patient-reported outcomes among rheumatoid arthritis patients with tDMARDs and bDMARDS in two Latin-American countries: A prospective observational study.
Juan Manuel Reyes-SanchezMagda V Gutierrez-ArdilaHugo MadariagaWilliam OteroRenato GuzmanJorge IzquierdoDavid J Del CastilloMauricio AbelloPatricia VelezDario Ponce de LeonTatjana LukicLuisa F AmadorGamboa N CastañoPublished in: Health science reports (2023)
This study suggested the access to treatment can affect the response to the treatment at 6 months of follow-up. There seems to be no effect in the PROs for delay of TtS during the studied period.